MARC Record from marc_columbia

LEADER: 05889cam a22004214a 4500
001 7241481
005 20221130223558.0
008 070622t20082008pauaf b 001 0 eng
010 $a 2007026228
020 $a9780781768795
020 $a0781768799
024 $a99934249545
035 $a(OCoLC)145942325
035 $a(OCoLC)ocn145942325
035 $a(NNC)7241481
035 $a7241481
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dMUQ$dYDXCP$dCOU$dC#P$dOrLoB-B
042 $apcc
050 00 $aRS403$b.P75 2008
060 00 $a2007 L-720
060 10 $aQV 744$bF7962 2008
082 00 $a616.07/56$222
245 00 $aFoye's principles of medicinal chemistry /$cedited by Thomas L. Lemke, David A. Williams ; assistant editors, Victoria F. Roche, S. William Zito [and others].
246 30 $aPrinciples of medicinal chemistry
250 $a6th ed.
260 $aPhiladelphia :$bLippincott Williams & Wilkins,$c[2008], ©2008.
300 $axiv, 1377 pages, 8 pages of plates :$billustrations (some color) ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tHistorical Perspective of Medicinal Chemistry /$rJohn L. Neumeyer -- $gPt. I.$tPrinciples of Drug Discovery -- $gCh. 1.$tDiscovery from Natural Products /$rA. Douglas Kinghorn -- $gCh. 2.$tDrug Design and Relationship of Functional Groups to Pharmacologic Activity /$rJames J. Knittel and Robin M. Zavod -- $gCh. 3.$tMolecular Modeling and In Silico Drug Design /$rXiang-Qun (Sean) Xie -- $gCh. 4.$tReceptors and Drug Action /$rTimothy A. Maher and David A. Johnson -- $gCh. 5.$tDrug Discovery Through Enzyme Inhibition /$rStephen Kerr -- $gCh. 6.$tPharmaceutical Biotechnology - From Nucleic Acids to Personalized Medicine /$rRonald E. Reid and Robert D. Sindelar -- $gCh. 7.$tPeptide and Protein Drugs /$rMichael Mokotoff -- $gCh. 8.$tAntisense Therapeutic Agents /$rMarilyn Speedie -- $gCh. 9.$tPhysicochemical and Biopharmaceutical Properties of Drug Substances and Pharmacokinetics /$rSunil S. Jambhekar -- $gCh. 10.$tDrug Metabolism /$rDavid A. Williams -- $gCh. 11.$tU.S. Drug Regulation: An Overview /$rDouglas J. Pisano -- $gPt. II.$tDrug Receptors Affecting Neurotransmission and Enzymes as Catalytic Receptors -- $tOverview of Drug Receptors: A Perspective /$rDavid J. Triggle -- $gCh. 12.$tDrugs Affecting Cholinergic Neurotransmission /$rE. Kim Fifer -- $gCh. 13.$tAdrenergic Receptors and Drugs Affecting Adrenergic Neurotransmission /$rRobert K. Griffith -- $gCh. 14.$tSerotonin Receptors and Drugs Affecting Serotonergic Neurotransmission /$rRichard A. Glennon and Malgorzata Dukat-Glennon -- $gCh. 15.$tAmino Acid Neurotransmitters in the Central Nervous System /$rTimothy J. Maher -- $gCh. 16.$tInhibitors of Nerve Conduction: Local Anesthetics /$rMatthias C. Lu -- $gCh. 17.$tPhosphodiesterase Inhibitors /$rKevin Dalby -- $gPt. III.$tPharmacodynamic Agents -- $gCh. 18.$tGeneral Anesthetics /$rTimothy J. Maher -- $gCh. 19.$tSedative-Hypnotics /$rWilliam Soine -- $gCh. 20.$tAntiseizure Agents /$rBarbara Leduc -- $gCh. 21.$tAntidepressants /$rDavid A. Williams -- $gCh. 22.$tPsychotherapeutic Drugs: Antipsychotic and Anxiolytic Agents /$rRaymond G. Booth -- $gCh. 23.$tHallucinogens, Stimulants and Related Drugs of Abuse /$rRichard A. Glennon -- $gCh. 24.$tOpioid Analgesics /$rDavid S. Fries -- $gCh. 25.$tDrugs Used to Treat Neuromuscular Disorders: Antiparkinsonian and Spasmolytic Agents /$rRaymond G. Booth -- $gCh. 26.$tCardiac Agents: Cardiac Glycosides, Antianginal, and Antiarrhythmic Drugs /$rAhmed S. Mehanna -- $gCh. 27.$tDiuretics /$rGary O. Rankin -- $gCh. 28.$tAngiotensin-Converting Enzyme Inhibitors, Antagonists and Calcium Blockers /$rMarc Harrold -- $gCh. 29.$tCentral and Peripheral Sympatholytics and Vasodilators /$rDavid A. Williams -- $gCh. 30.$tAntihyperlipoproteinemics and Inhibitors of Cholesterol Biosynthesis /$rMarc Harrold -- $gCh. 31.$tAntithrombotics, Thrombolytics, Coagulants, and Plasma Extenders /$rMatthias C. Lu and Thomas L. Lemke -- $gCh. 32.$tInsulin and Drugs Used for the Treatment of Diabetes /$rRobin M. Zavod, John L. Krstenansky and Bruce L. Currie -- $gCh. 33.$tAdrenocorticoids /$rDuane D. Miller, Robert W. Brueggemeier and James T. Dalton -- $gCh. 34.$tThyroid Function and Thyroid Drugs /$rAli R. Banijamali -- $gCh. 35.$tCalcium Homeostasis /$rRobin M. Zavod -- $gCh. 36.$tNonsteroidal Anti-Inflammatory Drugs /$rRonald Borne, Mark Levi and Norman Wilson -- $gCh. 37.$tAntihistamines and Related Antiallergic and Antiulcer Agents /$rWendel L. Nelson -- $gCh. 38.$tAntibiotics and Antimicrobial Agents /$rLester A. Mitscher, Thomas L. Lemke and Elmer J. Gentry -- $gCh. 39.$tAntiparasitic Agents /$rThomas L. Lemke -- $gCh. 40.$tAntifungal Agents /$rRobert K. Griffith -- $gCh. 41.$tAntimycobacterial Agents /$rThomas L. Lemke -- $gCh. 42.$tCancer and Chemotherapy /$rVictoria F. Roche -- $gCh. 43.$tAntiviral Agents and Protease Inhibitors /$rPatrick M. Woster -- $gPt. IV.$tDisease State Management -- $gCh. 44.$tAsthma and Chronic Obstructive Pulmonary Disease /$rS. William Zito -- $gCh. 45.$tMen's Health /$rDuane D. Miller, Robert W. Brueggemeier and James T. Dalton -- $gCh. 46.$tWomen's Health /$rRobin M. Zavod -- $gApp. A.$tpKa Values for Some Drugs and Miscellaneous Organic Acids and Bases -- $gApp. B.$tpH Values for Tissue Fluids.
650 0 $aPharmaceutical chemistry.$0http://id.loc.gov/authorities/subjects/sh85023026
650 6 $aChimie pharmaceutique.
650 12 $aChemistry, Pharmaceutical.$0https://id.nlm.nih.gov/mesh/D002626
700 1 $aFoye, William O.$0http://id.loc.gov/authorities/names/n80094476
700 1 $aLemke, Thomas L.$0http://id.loc.gov/authorities/names/n83198079
700 1 $aWilliams, David A.,$d1938-$0http://id.loc.gov/authorities/names/n94802324
852 00 $boff,eng$hRS403$i.P75 2008